Post Marketing Surveillance to Observe Safety and Effectiveness of CABOMETYX™ in Korea.
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 422
Summary
- Conditions
- Hepatocellular Carcinoma
- Renal Cell Carcinoma
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03776123
- Collaborators
- Not Provided
- Investigators
- Study Director: Ipsen Medical Director Ipsen
Get Well Soon